Premarin Vaginal Side Effects
Generic Name: conjugated estrogens topical
Note: This page contains side effects data for the generic drug conjugated estrogens topical. It is possible that some of the dosage forms included below may not apply to the brand name Premarin Vaginal.
It is possible that some side effects of Premarin Vaginal may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.
For the Consumer
Applies to conjugated estrogens topical: vaginal cream
As well as its needed effects, conjugated estrogens topical (the active ingredient contained in Premarin Vaginal) may cause unwanted side effects that require medical attention.
If any of the following side effects occur while taking conjugated estrogens topical, check with your doctor immediately:More common
- Breast pain
- change in vaginal discharge
- cough or hoarseness
- fever or chills
- increased clear or white vaginal discharge
- itching of the vagina or genital area
- lower back or side pain
- pain during sexual intercourse
- pain or feeling of pressure in the pelvis
- painful or difficult urination
- thick, white vaginal discharge with no odor or with a mild odor
- vaginal bleeding
- Feeling faint, dizzy, or lightheaded
- feeling of warmth or heat
- flushing or redness of the skin, especially on the face and neck
- Abdominal or stomach bloating
- abnormal uterine bleeding or spotting
- bloody or cloudy urine
- breast tenderness, enlargement, pain, or discharge
- chest pain or discomfort
- decreased vision or other changes in vision
- difficulty with swallowing
- enlargement of the penis or testes
- fast heartbeat
- frequent urge to urinate
- growth of pubic hair
- itching of the vagina or outside genitals
- pain during sexual intercourse
- pain or discomfort in the arms, jaw, back, or neck
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- rapid increase in height
- shortness of breath
- stomach pain
- sudden shortness of breath or troubled breathing
- tightness in the chest
- unusual tiredness or weakness
Some conjugated estrogens topical side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:More common
- Abdominal or stomach pain
- back pain
- lack or loss of strength
- Body aches or pain
- increased dryness or soreness of the throat
- runny nose
- tender, swollen glands in the neck
- trouble with swallowing
- voice changes
- Abdominal or stomach cramps
- changes in weight
- decreased or increased interest in sexual intercourse
- difficulty with moving
- headache, severe and throbbing
- heavy bleeding
- inability to have or keep an erection
- increased hair growth, especially on the face
- itching of the vagina or genitals
- leg cramps
- loss of scalp hair
- loss or increase in sexual ability, desire, drive, or performance
- mood changes
- muscle pain or stiffness
- pain in the joints
- patchy brown or dark brown discoloration of the skin
- poor insight and judgment
- problems with memory or speech
- swelling of the breasts or breast soreness in both females and males
- trouble recognizing objects
- trouble thinking and planning
For Healthcare Professionals
Applies to conjugated estrogens topical: vaginal cream with applicator
Oncologic side effects have included an increased risks of endometrial carcinoma, ovarian cancer, and breast cancer.
Cardiovascular side effects have included deep and superficial venous thrombosis, pulmonary embolism, thrombophlebitis, increase in blood pressure, and myocardial infarction.
The manufacturer recommends close observation if conjugated estrogens must be used in patients who may be particularly sensitive to fluid retention because of underlying asthma, epilepsy, migraine, heart disease, and renal dysfunction.
Genitourinary side effects have included breakthrough bleeding, spotting, changes in vaginal bleeding pattern, abnormal withdrawal bleeding or flow, dysmenorrhea, increase the size of preexisting uterine leiomyomata, vaginitis, including vaginal candidiasis, change in cervical erosion and in degree of cervical secretion, cystitis like syndrome, application site reactions of vulvovaginal discomfort including burning and irritation, genital pruritus, ovarian cancer, endometrial hyperplasia, and precocious puberty. Additional side effects have included breast enlargement, breast pain, dysuria, leukorrhea, metrorrhagia, urinary frequency, urinary tract infection, urinary urgency, vaginal hemorrhage, vaginal moniliasis, vaginitis, and vulvovaginal disorder.
Metabolic side effects have included increased serum triglyceride levels and reduced carbohydrate tolerance. Aggravation of porphyria has been reported.
General side effects have included reports of fluid retention, and increase or decrease in weight.
Gastrointestinal side effects have included nausea, vomiting, abdominal cramps, bloating, cholestatic jaundice, pancreatitis, and increased incidence of gallbladder disease. Ischemic colitis has also been reported.
Hematologic side effects have included hypercoagulability. Several cases of the hemolytic uremic syndrome have also been associated with conjugated estrogen therapy.
Many of the reports of hepatic tumors have occurred in women taking long-term oral contraceptives. However, some tumors have been reported in women taking isolated estrogen therapy.
Hepatic side effects have included enlargement of hepatic hemangiomas and rare cases of focal nodular hyperplasia, liver cell adenomas, hepatic hemangiomas and well differentiated hepatocellular carcinomas.
Nervous system side effects have included migraine, dizziness, nervousness, mood disturbances, irritability, chorea, exacerbation of epilepsy, dementia, and mental depression. Possible growth potentiation of benign meningioma has also been reported.
Other side effects have included breast tenderness, pain, enlargement, secretion, and fibrocystic breast changes. Postmarketing experience has included reports of gynecomastia in males.
Psychiatric side effects have included reports of rapid mood cycling in patients with severe depression.
Hypersensitivity side effects have been reported in postmarketing experience.
Respiratory side effects have included pulmonary embolism, exacerbation of asthma, and rare cases of exacerbations of pulmonary lymphangioleiomyomatosis. In addition, combinations of high-dose conjugated estrogens and progestin have been reported to increase ventilation and increase the hypoxic ventilatory response.
Dermatologic side effects have included chloasma or melasma, which did not always resolve following discontinuation of estrogen therapy, scalp hair loss, hirsutism, erythema multiforme, erythema nodosum, rash, pruritus, and hemorrhagic eruptions. Acne and erythema have also been reported.
Endocrine side effects have included increased levels of thyroxin-binding globulin, leading to an increase in total thyroid serum levels and a decrease in resin uptake of T3. Free thyroid hormone levels remain unchanged. Other endocrine effects include decreased fasting plasma glucose.
Ocular side effects have included retinal vascular thrombosis and intolerance to contact lenses.
Musculoskeletal side effects have included muscle cramps.
More about Premarin Vaginal (conjugated estrogens topical)
- Other brands: Synthetic Conjugated Estrogens A
Related treatment guides
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.